How common air and water chemicals affect early development

Developmental VOC Exposure in Zebrafish: Toxic Mechanisms and Biomarkers

NIH-funded research Wayne State University · NIH-11122281

Researchers are examining whether common volatile chemicals found in cities can harm developing babies and whether there are biological markers that show such exposure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWayne State University NIH-funded
Lab location1 site (Detroit, United States)
Project IDNIH-11122281 on NIH RePORTER

What this research studies

This project uses zebrafish, a widely accepted animal model, to mimic how low-level mixtures of volatile organic compounds (VOCs) people encounter affect growth, immune function, and reproductive health. Scientists will expose zebrafish to environmentally relevant VOC mixtures and use fast, high-throughput lab methods to measure development, behavior, and molecular changes. The team aims to identify biomarkers in the fish that could later help detect harmful exposures in people and connect those exposures to outcomes like preterm birth. The work is centered at Wayne State in Detroit and is motivated by local concerns about VOC contamination and high preterm birth rates.

Who could benefit from this research

Good fit: People most relevant to this research are pregnant people, new parents, and residents of urban or contaminated areas who are concerned about VOC exposure and its effects on developing babies.

Not a fit: Individuals seeking immediate clinical treatment for an existing medical condition or those with health issues unrelated to environmental chemical exposure are unlikely to get direct benefit from this basic laboratory research.

Why it matters

Potential benefit: If successful, this work could lead to tests or markers that identify harmful VOC exposure early and inform steps to prevent developmental problems such as preterm birth.

How similar studies have performed: Zebrafish have been used successfully to study developmental toxicity and some exposure biomarkers exist, but applying high-throughput mixtures testing and translating those markers to human preterm birth risk is relatively novel.

Where this research is happening

Detroit, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.